4th International suPAR Symposium

New horizons for suPAR: Risk stratification, organ dysfunction and relevance for specific diseases.

Thank you for your participation in the 4´th International suPAR Symposium. Presentations from the Symposium are uploaded in the Programme under each speaker, please look further down on this page.

4th International suPAR symposium Overview

As the proud sponsor of the 4’th International suPAR Symposium celebrated in Aachen, Germany on Feb. 25-26, 2013, ViroGates wishes to thank this years two outstanding hosts Prof. Frank Tacke and assist. Prof. Alexander Koch along with all speakers and other delegates for their contribution to a highly successful meeting.

The 1½ days at the Super C in central Aachen revealed high quality presentations with interesting and productive discussions subsequently.

There is an increasing interest in doing studies with the suPAR biomarker. The intention to present on the one hand novel original data on this topic and on the other hand aim at summarizing the current knowledge on suPAR by the leading experts in the specific areas of clinical and basic research was very well met in the 6 planned sessions:

Data further uncovering the utility and value of suPAR was discussed, and new ideas for new and ongoing studies sprouted.

Early Triaging of critical cases was also discussed: It seems that suPAR could be the right marker to pre-select patients with more urgency.

Inflammation - Diagnosis, Disease Progression and Prognosis – suPAR is a strong biomarker in patients with multiple medical diseases and can potentially be used as a prognostic marker for kidney, liver and heart organ failures, and as a diagnostic marker for Kidney FSGS. In addition there seems to be strong evidences that suPAR predominantly represents endothelial damage and atherosclerosis, whereas CRP seems predominantly to represent metabolic inflammation. In the general population, suPAR and the combination of suPAR and CRP add prognostic CVD risk information above and beyond the Framingham Risk Score.